Yuzhen Wang

Yuzhen Wang

Auto-generated profile, based on publicly available information

Yuzhen Wang

Key Laboratory of Flexible Electronics & Institute of Advanced Materials, Jiangsu National Synergistic Innovation Center for Advanced Materials, Nanjing Tech University, Nanjing 211816, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
YPYongchun Pan
Yongchun Pan
JYJingjing Yang
Jingjing Yang
XLXiaowei Luan
Xiaowei Luan
XLXinli Liu
Xinli Liu
XLXueqing Li
Xueqing Li
YSYujun Song
Yujun Song
As an RNA-guided nuclease, CRISPR-Cas9 offers facile and promising solutions to mediate genome modification with respect to versatility and high precision. However, spatiotemporal manipulation of CRISPR-Cas9 delivery remains a daunting challenge for robust effectuation of gene editing both in vitro and in vivo. Here, we designed a near-infrared (NIR) light–responsive nanocarrier of CRISPR-Cas9 for cancer therapeutics based on upconversion nanoparticles (UCNPs). The UCNPs served as “nanotransducers” that can convert NIR light (980 nm) into local ultraviolet light for the cleavage of photosensitive molecules, thereby resulting in on-demand release of CRISPR-Cas9. In addition, by preparing a single guide RNA targeting a tumor gene (polo-like kinase-1), our strategies have successfully inhibited the proliferation of tumor cell via NIR light–activated gene editing both in vitro and in vivo. Overall, this exogenously controlled method presents enormous potential for targeted gene editing in deep tissues and treatment of a myriad of diseases.

15 February 2023 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
YWYanping Wang
Yanping Wang
YGYanfeng Gao
Yanfeng Gao
YPYongchun Pan
Yongchun Pan
DZDongtao Zhou
Dongtao Zhou
YLYuta Liu
Yuta Liu
YSYujun Song
Yujun Song
New drug discovery is under growing pressure to satisfy the demand from a wide range of domains, especially from the pharmaceutical industry and healthcare services. Assessment of drug efficacy and safety prior to human clinical trials is a crucial part of drug development, which deserves greater emphasis to reduce the cost and time in drug discovery. Recent advances in microfabrication and tissue engineering have given rise to organ-on-a-chip, an in vitro model capable of recapitulating human organ functions in vivo and providing insight into disease pathophysiology, which offers a potential alternative to animal models for more efficient pre-clinical screening of drug candidates. In this review, we first give a snapshot of general considerations for organ-on-a-chip device design. Then, we comprehensively review the recent advances in organ-on-a-chip for drug screening. Finally, we summarize some key challenges of the progress in this field and discuss future prospects of organ-on-a-chip development. Overall, this review highlights the new avenue that organ-on-a-chip opens for drug development, therapeutic innovation, and precision medicine.

1 October 2021 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
QZQiao Zhao
Qiao Zhao
YPYongchun Pan
Yongchun Pan
XLXiaowei Luan
Xiaowei Luan
YGYanfeng Gao
Yanfeng Gao
XZXiaozhi Zhao
Xiaozhi Zhao
YSYujun Song
Yujun Song

20 February 2020 in Nano Research
Verified
Journal Article
Closed access
PDF file
XLXinli Liu
Xinli Liu
YPYongchun Pan
Yongchun Pan
JYJingjing Yang
Jingjing Yang
YGYanfeng Gao
Yanfeng Gao
THTing Huang
Ting Huang
YSYujun Song
Yujun Song
We report gold nanoparticles (AuNPs) doped iron-based metal-organic frameworks (GIM) which displays near-infrared light (NIR)-enhanced cascade nanozyme against hypoxic tumors. Due to the strong protein adsorption-induced surface passivation, AuNPs suffer from the loss of glucose oxidase (GOx) activity. However, GIM could protect the GOx-like activity of AuNPs with the satisfactory shield capability. In addition, GIM exhibited excellent photothermal conversion ability and unique NIR light-enhanced GOx-like activity, which could efficiently increase the endogenous H2O2 production. Meanwhile, as the produced H2O2 is converted by GIM into O2 and highly toxic OH. Thus, GIM-catalyzed cascade reactions with NIR light irradiation not only offer the O2 but also promote the reactive oxygen species (ROS) generation at tumor sites. The produced O2 could be further applied to AuNPs catalytic oxidation of glucose and relieve hypoxic condition of tumor microenvironment (TME). As a proof-of-concept study, GIM demonstrates the admirable tumor ablation under NIR irradiation in vivo.

1 October 2018 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
XLXinli Liu
Xinli Liu
YWYuzhen Wang
Yuzhen Wang
YSYujun Song
Yujun Song

27 February 2023 in ACS Nano
Verified
Journal Article
Closed access
YPYongchun Pan
Yongchun Pan
XLXiaowei Luan
Xiaowei Luan
YGYanfeng Gao
Yanfeng Gao
FZFei Zeng
Fei Zeng
XWXuyuan Wang
Xuyuan Wang
YSYujun Song
Yujun Song